| #1 | | | Baku, Azerbaijan | | 8+ years | Immunotherapy with Keytruda (Pembrolizumab), Immunotherapy for prostate cancer, Immunotherapy for lung cancer, Immunotherapy for breast cancer, Immunotherapy for kidney cancer | Patients with high tumor mutational burden | Specializes in immunotherapy for various cancers, including prostate, lung, breast, and kidney. JCI accredited with 100% compliance. Offers Keytruda treatment and requires BRCA1/2 testing for personalized care. | Joint Commission International , Patient choice for Check-up |